Lifeyear
In clinical use since January 2026

Cardio­metabolic care beyond the clinic

Lifeyear helps care teams manage patients between appointments with less work. Starting with the largest caseload in healthcare - long-term heart, kidney and metabolic conditions.

Shareholder

  • Oxford University Hospitals NHS Foundation Trust

Investors

  • Verge HealthTech Fund
  • Tilia Impact Ventures
  • PurposeTech

Recognition

  • Global Entrepreneur Programme, GREAT Britain and Northern Ireland
  • European Society of Cardiology

    Abstract accepted 2026

  • EY

    Ripples programme

The burden

Cardiometabolic disease is the biggest burden on health systems worldwide

UK adults at cardiometabolic risk
34M+
annual cost in England
£24B
Europeans with cardiovascular disease
62M
annual cost in the EU
€282B
US adults at cardiometabolic risk
~240M
annual cost in the US by 2050
$1.8T

Sources: BHF, 2025-26 · European Commission, 2025 · JAMA, 2024 · AHA, 2024

The patient has changed. The practice has stayed the same. The system has run out of capacity.

Dr Eleanor Wicks

Co-founder and CMO · Consultant Cardiologist, 20+ years in the NHS

The gap

Real life happens between appointments

Follow-up is a few clinic slots a year. Deterioration, missed doses and stalled treatment happen in between. Lifeyear helps the care team see what happens in those months and act on it, with less work.

A year of usual care

A few appointments. The rest goes unseen.

A year with Lifeyear

Readings at home, checked automatically. The care team sees who needs a decision.

How it works

Readings at home. Checked by the platform. Decisions by the care team.

The whole remote care delivery system - software, home devices, managed review and implementation support.

  1. Patient app on a phone with a connected scale and blood pressure monitor
    1

    The patient takes readings at home

    A guided care plan in the patient app, reminders, education and home devices.

  2. 2

    Our system checks every reading

    It uses guideline-based thresholds to escalate only the patients who need a clinical decision.

  3. Care team workspace showing a patient's readings, medication and thresholds
    3

    The care team stays in control

    The care team workspace shows who needs attention, and helps the care team act on it.

Who it's for

Built for NHS trusts, primary care and private providers

  • NHS trusts

    Post-discharge monitoring and treatment optimisation for cardiology services. With managed review, your team sees only the patients who need a clinical decision.

  • Primary care

    We find patients who are off target on the QOF CVD prevention indicators and follow them up at home, with progress reported against your indicators.

  • Private providers

    Cardiac care that continues after the consultation. You keep the patient relationship and clinical governance; we provide the platform.

Pathways

Enrol a patient once. Switch on pathways as needed.

  • Heart failure

    In clinical use

    Post-discharge monitoring, medication optimisation and community follow-up.

  • Cardiac rehabilitation

    2027

    Remote rehabilitation and secondary prevention after a cardiac event.

  • Lipids

    2027

    LDL-C to target before or after an event.

  • Hypertension

    2027

    Blood pressure to target through remote monitoring and medication optimisation.

  • Cardiorenal

    2027

    SGLT2 inhibitor and finerenone initiation in heart and kidney disease.

  • Obesity

    2027

    Monitoring and follow-up alongside GLP-1 based weight management.

Evidence

Proven in clinical use. Building the evidence on outcomes.

20,000+

vitals and medication logs since January 2026

Two Estonian hospitals

95%+

patient adherence to daily readings

North Estonia Medical Centre

2-3 min

of clinician review per patient per week

North Estonia Medical Centre

120

patients in a randomised trial, outcomes in 2027

Tartu University Hospital

Assurance

Cyber Essentials
Certified
NHS DSPT
Standards Met
NHS DTAC
Certified, May 2026
Penetration test
Astra Security, grade A+
UK and EU GDPR
Compliant

DCB0129 and DCB0160 complete, DPIA in place, UK data hosting. Request the IG and clinical safety pack

Dr Eleanor Wicks

Built with cardiologists

Modern cardiology is digital-first and cardiometabolic. We built Lifeyear for the specialist teams delivering that shift.

Dr Eleanor Wicks

Co-founder and Chief Medical Officer

  • MBChB, BSc, PhD, FESC, FRCP
  • Honorary Consultant Cardiologist, Oxford University Hospitals NHS Trust
  • Chief Scientific Officer, London/Zurich Heart House
  • Secretary, British Inherited Cardiovascular Conditions Society (BICCS)

For providers

Talk to a cardiologist, not a salesperson

A 30-minute conversation with Dr Eleanor Wicks about your service and how we can help.

Book a conversation

For investors

Invest in Lifeyear

If you invest in healthtech and want to help take cardiometabolic care beyond the clinic, get in touch.

Get in touch